You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TNFα

Showing 1 - 25 of 796
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Spinal Cord Injuries Trial in Shanghai (TNFa Monoclonal Antibody, Methylprednisolone, Saline)

Not yet recruiting
  • Spinal Cord Injuries
  • TNFα Monoclonal Antibody
  • +2 more
  • Shanghai, China
    Shanghai Changzheng Hospital
May 4, 2022

Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

Completed
  • Acute Graft-versus-host Disease
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 11, 2023

    Rheumatoid Arthritis Trial in Palmetto Bay, Lincoln, Duncansville (TC99m-tilmanocept)

    Recruiting
    • Rheumatoid Arthritis
    • Palmetto Bay, Florida
    • +2 more
    May 9, 2022

    Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

    Completed
    • Advanced Solid Tumors Amenable to Anthracycline Therapy
    • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
    • Münster, Germany
    • +1 more
    Apr 1, 2022

    Diabetes, Type 1 Trial (Golimumab, Placebo)

    Withdrawn
    • Diabetes Mellitus, Type 1
    • (no location specified)
    Nov 19, 2021

    Low Back Pain Trial in Islamabad (• Blood Markers CRP, TNFa, IL-6, IL-8, IL-1, and IL-1ß AND FIBRINOGEN)

    Not yet recruiting
    • Low Back Pain
    • • Blood Markers CRP, TNFα, IL-6, IL-8, IL-1, and IL-1β AND FIBRINOGEN
    • Islamabad, Pakistan
      KRL Hospital
    Feb 20, 2023

    Pediatric HSCT Recipients With aGVHD: Prospective Observational

    Recruiting
    • Graft Versus Host Disease, Acute
    • Hematopoietic Stem Cell Transplantation
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Apr 30, 2022

      Rheumatoid Arthritis Trial in Worldwide (ABX464 50mg, Matching Placebo, ABX464 100mg)

      Completed
      Has Results
      • Rheumatoid Arthritis
      • ABX464 50mg
      • +3 more
      • Bruxelles, Belgium
      • +23 more
      Feb 3, 2022

      Psoriatic Arthritis Trial in Germany (Secukinumab, Ustekinumab)

      Recruiting
      • Psoriatic Arthritis
      • Secukinumab
      • Ustekinumab
      • Frankfurt, Hesse, Germany
      • +36 more
      Jul 20, 2022

      Solid Tumor Trial in Helsinki (TILT-123)

      Recruiting
      • Solid Tumor
      • TILT-123
      • Helsinki, Uusima, Finland
      • +1 more
      Dec 17, 2021

      Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)

      Active, not recruiting
      Has Results
      • Arthritis, Juvenile
      • San Diego, California
      • +37 more
      Jan 17, 2023

      Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo, Apremilast)

      Recruiting
      • Psoriatic Arthritis
      • Birmingham, Alabama
      • +136 more
      Jul 29, 2022

      Theranostic Test to PREDict Treatment Response of Anti-TNFa

      Terminated
      • RheumatoId Arthritis
      • Infliximab
      • +6 more
      • Prague, Czechia
      • +7 more
      Dec 21, 2019

      Rheumatoid Arthritis Trial in Australia, United States (Allogeneic Mesenchymal Precursor Cells, Normal Saline)

      Completed
      • Rheumatoid Arthritis
      • Allogeneic Mesenchymal Precursor Cells
      • Normal Saline
      • Anniston, Alabama
      • +22 more
      Jun 25, 2020

      Psoriasis and Non Alcoholic Steatohepatitis: Is ThereShared

      Not yet recruiting
      • Nash
        • (no location specified)
        Aug 15, 2023

        Irritable Bowel Syndrome Trial in Giza (( low FODMAP diet ), (Pilates exercises))

        Not yet recruiting
        • Irritable Bowel Syndrome
        • ( low FODMAP diet )
        • (Pilates exercises)
        • Giza, Egypt
          faculty of physical therapy, Cairo university
        Apr 15, 2023

        Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)

        Recruiting
        • Ulcerative Colitis
        • Thromboembolism
        • Madrid, Spain
          Hospital Universitario de La Princesa
        Aug 2, 2022

        SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)

        Withdrawn
        • SARS-CoV 2
        • +5 more
        • ZYESAMI™ (aviptadil acetate)
        • +2 more
        • (no location specified)
        Feb 2, 2023

        SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or

        Terminated
        • SARS-CoV 2
        • +5 more
        • ZYESAMI™ (aviptadil acetate)
        • +2 more
        • Fullerton, California
        • +12 more
        Feb 2, 2023

        Ustekinumab and Tofacitinib as Third Line Therapy inMulticenter

        Completed
        • Ulcerative Colitis
        • Milano, Italy
          Mariangela Allocca
        Feb 13, 2023

        Colitis, Ulcerative Trial in Worldwide (Golimumab, Infliximab)

        Recruiting
        • Colitis, Ulcerative
        • San Francisco, California
        • +64 more
        Aug 17, 2022

        Intermittent Fasting Trial in Istanbul (Intermittent fasting)

        Completed
        • Intermittent Fasting
        • Intermittent fasting
        • Istanbul, Turkey
          Istanbul Training and Research Hospital
        Jun 1, 2022

        Assisted Reproduction Trial in Nice (Unique blod sample)

        Not yet recruiting
        • Assisted Reproduction
        • Unique blod sample
        • Nice, France
          Chu de Nice
        Mar 13, 2023

        The Immu-KNEE-ty Study

        Not yet recruiting
        • Immunosenescence
        • Aging
        • Knee arthroplasty
        • Ede, Netherlands
          Gelderse Vallei Hospital
        Jun 15, 2023

        Cancer, Myeloid Tumor Trial in Rochester (GO-EXCAP Mobile App, Behavioral Placebo Control)

        Recruiting
        • Cancer
        • Myeloid Neoplasm
        • GO-EXCAP Mobile App
        • Behavioral Placebo Control
        • Rochester, New York
          University of Rochester Medical Center/Wilmot Cancer Institute
        Jan 4, 2022